Laboratory Considerations for Clinical Trials
Science:Life Sciences
In this episode, Drs. Steven Lowes and Barry Jones discuss hybrid assays, combining immuno-affinity with liquid chromatography-mass spectrometry (LC-MS). This is a growing area of opportunity for protein bioanalysis.
Topics covered include:
- What is meant by hybrid assay
- Reasons to choose a hybrid assay
- Top down vs bottom up
- Specific challenges
- Assay design considerations
- Future potential for this type of bioanalysis
...I think that fundamental point about more sensitivity, and associated with that is more selectivity, is going to be part of the future adoption of these hybrid assays. We have needs already, we can see needs for looking at quantifying proteins in very small samples, say tissue biopsies. - Steven Lowes
Learn more at Q2labsolutions.com.
Protein Biomarker Quantification by Immunoaffinity Liquid Chromatography–Tandem Mass Spectrometry: Current State and Future Vision (Article in Clinical Chemistry)
More Episodes
2022-06-22
191
2022-05-16
157
2021-09-14
200
2021-08-26
179
2021-07-30
148
2021-07-28
155
2021-07-28
148
2021-02-02
135
2020-09-15
181
2020-07-29
87
2020-07-29
110
2019-02-26
178
Get this podcast on your
phone, FREE
Create your
podcast in
minutes
- Full-featured podcast site
- Unlimited storage and bandwidth
- Comprehensive podcast stats
- Integrate with iTunes and Google
store - Make money with your podcast
It is Free
